Genovis AB
STO:GENO

Watchlist Manager

Genovis AB

STO:GENO

Watchlist

Discount Rate

Price: 22.75 SEK 0.22% Market Closed

Market Cap: 1.5B SEK

Have any thoughts about
Genovis AB?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Berkshire Hathaway Inc NYSE:BRK.A	Financial Services
US	Bank of America Corp NYSE:BAC	Banking
US	Mastercard Inc NYSE:MA	Technology
US	Abbvie Inc NYSE:ABBV	Biotechnology
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	3M Co NYSE:MMM	Industrial Conglomerates
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Realty Income Corp NYSE:O	Real Estate
US	Walt Disney Co NYSE:DIS	Media
US	PayPal Holdings Inc NASDAQ:PYPL	Technology

Add Price Alert

Price Target:

Last Price: 22.75 SEK

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

GENO Alert

Genovis AB

22.75

+0.05 (+0.22%)

52 Week Range	22.7 53.6
Price Target

We'll email you a reminder when the closing price reaches SEK.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Berkshire Hathaway Inc NYSE:BRK.A	US
	Bank of America Corp NYSE:BAC	US
	Mastercard Inc NYSE:MA	US
	Abbvie Inc NYSE:ABBV	US
	Pfizer Inc NYSE:PFE	US
	Palantir Technologies Inc NYSE:PLTR	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	3M Co NYSE:MMM	US
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Realty Income Corp NYSE:O	US
	Walt Disney Co NYSE:DIS	US
	PayPal Holdings Inc NASDAQ:PYPL	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Genovis AB

What unique competitive advantages
does Genovis AB hold over its rivals?

What risks and challenges
does Genovis AB face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Genovis AB.

What unique competitive advantages
does Genovis AB hold over its rivals?

What risks and challenges
does Genovis AB face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Genovis AB.

Provide P/S
for Genovis AB.

Provide P/E
for Genovis AB.

Provide P/OCF
for Genovis AB.

Provide P/FCFE
for Genovis AB.

Provide P/B
for Genovis AB.

Provide EV/S
for Genovis AB.

Provide EV/GP
for Genovis AB.

Provide EV/EBITDA
for Genovis AB.

Provide EV/EBIT
for Genovis AB.

Provide EV/OCF
for Genovis AB.

Provide EV/FCFF
for Genovis AB.

Provide EV/IC
for Genovis AB.

Show me price targets
for Genovis AB made by professional analysts.

What are the Revenue projections
for Genovis AB?

How accurate were the past Revenue estimates
for Genovis AB?

What are the Net Income projections
for Genovis AB?

How accurate were the past Net Income estimates
for Genovis AB?

What are the EPS projections
for Genovis AB?

How accurate were the past EPS estimates
for Genovis AB?

What are the EBIT projections
for Genovis AB?

How accurate were the past EBIT estimates
for Genovis AB?

Compare the revenue forecasts
for Genovis AB with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Genovis AB and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Genovis AB against its competitors.

Analyze the profit margins
(gross, operating, and net) of Genovis AB compared to its peers.

Compare the P/E ratios
of Genovis AB against its peers.

Discuss the investment returns and shareholder value creation
comparing Genovis AB with its peers.

Analyze the financial leverage
of Genovis AB compared to its main competitors.

Show all profitability ratios
for Genovis AB.

Provide ROE
for Genovis AB.

Provide ROA
for Genovis AB.

Provide ROIC
for Genovis AB.

Provide ROCE
for Genovis AB.

Provide Gross Margin
for Genovis AB.

Provide Operating Margin
for Genovis AB.

Provide Net Margin
for Genovis AB.

Provide FCF Margin
for Genovis AB.

Show all solvency ratios
for Genovis AB.

Provide D/E Ratio
for Genovis AB.

Provide D/A Ratio
for Genovis AB.

Provide Interest Coverage Ratio
for Genovis AB.

Provide Altman Z-Score Ratio
for Genovis AB.

Provide Quick Ratio
for Genovis AB.

Provide Current Ratio
for Genovis AB.

Provide Cash Ratio
for Genovis AB.

What is the historical Revenue growth
over the last 5 years for Genovis AB?

What is the historical Net Income growth
over the last 5 years for Genovis AB?

What is the current Free Cash Flow
of Genovis AB?

Discuss the annual earnings per share (EPS)
trend over the past five years for Genovis AB.

P/E
Price to Earnings

86.3

Current

89.5

Median

31.1

Industry

Lower than median

Higher than industry value

Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.

P/E

86.3

Market Cap

1.5B SEK

Net Income

17.3m SEK

All Countries

Forward Multiples

			Market Cap	P/E
SE	G	Genovis AB STO:GENO	1.5B SEK	86.3
US	P	PerkinElmer Inc LSE:0KHE	1.4T USD	8 006.9
US		Thermo Fisher Scientific Inc NYSE:TMO	232.4B USD	37.4
US		Danaher Corp NYSE:DHR	196.9B USD	46.8
KR		Samsung Biologics Co Ltd KRX:207940	70.5T KRW	68.5
CH		Lonza Group AG SIX:LONN	38.5B CHF	67.3
US		IQVIA Holdings Inc NYSE:IQV	44.7B USD	31.4
US		Agilent Technologies Inc NYSE:A	39.7B USD	28.1
US		Mettler-Toledo International Inc NYSE:MTD	29.8B USD	37.9
IE		ICON PLC NASDAQ:ICLR	25.3B USD	35.4
US		West Pharmaceutical Services Inc NYSE:WST	22.6B USD	43.1

				Earnings Growth
SE	G	Genovis AB STO:GENO	Average P/E: 771.7 86.3	3%
US	P	PerkinElmer Inc LSE:0KHE	8 006.9	6%
US		Thermo Fisher Scientific Inc NYSE:TMO	37.4	74%
US		Danaher Corp NYSE:DHR	46.8	49%
KR		Samsung Biologics Co Ltd KRX:207940	68.5	72%
CH		Lonza Group AG SIX:LONN	67.3	112%
US		IQVIA Holdings Inc NYSE:IQV	31.4	90%
US		Agilent Technologies Inc NYSE:A	28.1	47%
US		Mettler-Toledo International Inc NYSE:MTD	37.9	32%
IE		ICON PLC NASDAQ:ICLR	35.4	165%
US		West Pharmaceutical Services Inc NYSE:WST	43.1	14%

P/E Forward Multiples

Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward

P/E

35.1

2-Years Forward

P/E

31.2

3-Years Forward

P/E

23.6

Genovis AB
STO:GENO

P/E
Price to Earnings

P/E Forward Multiples

See Also

Company

Help

Tools

Stocks

Genovis AB STO:GENO

P/E Price to Earnings

P/E Forward Multiples

See Also

Company

Help

Tools

Stocks

Genovis AB
STO:GENO

P/E
Price to Earnings